Syngene is a biotech company offering a wide range of equipment for instant gel documentation, automated chemiluminescence imaging and TLC plate reading.
Probiogen is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider, mainly focusing on cell line engineering, process development and GMP manufacturing of biopharmaceuticals.
CEVEC aims to become the leading independent player for human cell line based clinical materials. CEVEC offers the human amniocyte based protein expression platform CAP for the transient and stable production of biopharmaceuticals.
Posted in Biotech Companies, Biotech Companies Germany	| Tagged amniocyte, amniocyte based protein expression, amniocyte protein expression, Aristotelis Nastos, authentic post-translational modifications, authentic sialylation, CAP, CEVEC, CEVEC - human cells for human pharmaceuticals, CEVEC Amniocyte Production, CEVEC's Amniocyte Production, cGMP compliant Contract Manufacturing Services, Christian Leikert, Frank Ubags, glycoprotein, glycoproteins, Glycosylation, Hartmut Tintrup, human amniocyte, human amniocyte based protein expression, human amniocyte based protein expression platform, human amniocyte based protein expression platform CAP, human amniocytes, human cell line based clinical material, human cell line based clinical materials, human cell-based expression system, human cell-based expression systems, human cells, human cells for human pharmaceuticals, human cells human pharmaceuticals, human pharmaceuticals, Joachim Rautter, Klaus Zimmermann, master cell bank, MCB, Nicole Faust, original human glycosylation, primary human amniocyte, primary human amniocytes, production complex human therapeutic protein, production complex human therapeutic proteins, protein expression, PTM, Rainer Christine, serum-free suspension culture, sialylation, Stefan Kochanek, Wolfgang Kintzel